Literature DB >> 11318527

Collapsing focal segmental glomerulosclerosis with recovery of renal function: an uncommon complication of interferon therapy for hepatitis C.

D F Stein1, A Ahmed, V Sunkhara, W Khalbuss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11318527     DOI： 10.1023/a:1005638913487

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  24 in total

Review 1.  The interferon system in acute and chronic viral hepatitis.

Authors:  M Peters; G L Davis; J S Dooley; J H Hoofnagle
Journal:  Prog Liver Dis       Date:  1986

2.  Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b.

Authors:  M Jadoul; H Piessevaux; A Ferrant; J P Cosyns; C van Ypersele de Strihou
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

Review 3.  Interferon-induced acute renal failure: a case report and literature review.

Authors:  R Horowitz; D Glicklich; L B Sablay; P H Wiernik; S Wadler
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

Review 4.  Renal manifestations of hepatitis C virus infection.

Authors:  R J Johnson; R Willson; H Yamabe; W Couser; C E Alpers; M H Wener; C Davis; D R Gretch
Journal:  Kidney Int       Date:  1994-11       Impact factor: 10.612

5.  Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides.

Authors:  S D Averbuch; H A Austin; S A Sherwin; T Antonovych; P A Bunn; D L Longo
Journal:  N Engl J Med       Date:  1984-01-05       Impact factor: 91.245

6.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

Review 7.  Clinical toxicity of interferons in cancer patients: a review.

Authors:  J R Quesada; M Talpaz; A Rios; R Kurzrock; J U Gutterman
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

8.  Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia.

Authors:  S Sacchi; H Kantarjian; S O'Brien; P R Cohen; S Pierce; M Talpaz
Journal:  J Clin Oncol       Date:  1995-09       Impact factor: 44.544

9.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

10.  Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy.

Authors:  R J Johnson; D R Gretch; W G Couser; C E Alpers; J Wilson; M Chung; J Hart; R Willson
Journal:  Kidney Int       Date:  1994-12       Impact factor: 10.612
View more
  6 in total

1.  Nephrotic syndrome with pegylated interferon alfa 2a and ribavirin for a patient with chronic hepatitis C.

Authors:  Ajit Sood; Vandana Midha; Jaswinder S Sandhu; Neena Sood; Amarjit Kaur; Rasham Mittal; Sandeep Puri
Journal:  Indian J Gastroenterol       Date:  2010-06

2.  Familial collapsing focal segmental glomerulosclerosis.

Authors:  V Liakopoulos; A Huerta; S Cohen; M R Pollak; R A Sirota; K Superdock; G B Appel
Journal:  Clin Nephrol       Date:  2011-04       Impact factor: 0.975

3.  Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.

Authors:  Glen S Markowitz; Samih H Nasr; M Barry Stokes; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

4.  Collapsing glomerulopathy as a complication of interferon therapy for hepatitis C infection.

Authors:  Sriraj Kanungo; Srinath Tamirisa; Rajalakshmi Gopalakrishnan; Luis Salinas-Madrigal; Bahar Bastani
Journal:  Int Urol Nephrol       Date:  2009-06-04       Impact factor: 2.370

Review 5.  De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).

Authors:  Fabrizio Fabrizi; Alessio Aghemo; Gabriella Moroni; Patrizia Passerini; Roberta D'Ambrosio; Paul Martin; Piergiorgio Messa
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.487

6.  Collapsing glomerulopathy after hepatitis C pegylated interferon treatment. Recovery of renal function with high-dose steroid treatment.

Authors:  Roberto H Berdichevski; Eduardo M De Carvalho; Maria Isabel Edelweiss; Luiz Felipe Gonçalves; Roberto C Manfro
Journal:  NDT Plus       Date:  2010-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.